Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by α2 adrenoceptor agonist dexmedetomidine

被引:131
作者
Chiu, Kuan-Ming [2 ,4 ]
Lin, Tzu-Yu [3 ,5 ]
Lu, Cheng-Wei [3 ]
Wang, Su-Jane [1 ,6 ]
机构
[1] Fu Jen Catholic Univ, Sch Med, New Taipei City 24205, Taiwan
[2] Far Eastern Mem Hosp, Ctr Cardiovasc, New Taipei City 220, Taiwan
[3] Far Eastern Mem Hosp, Dept Anesthesiol, New Taipei City 220, Taiwan
[4] Oriental Inst Technol, Dept Eldercare, Taipei, Taiwan
[5] Yuan Ze Univ, Dept Mech Engn, Tao Yuan 320, Taiwan
[6] Fu Jen Catholic Univ, Grad Inst Basic Med, New Taipei City 24205, Taiwan
关键词
Dexmedetomidine; alpha(2) adrenoceptor agonist; Glutamate release; Voltage-dependent Ca(2+) channel; Mitogen-activated protein kinase; Synaptosome; PROTEIN-KINASE-C; INCOMPLETE CEREBRAL-ISCHEMIA; SYNAPSIN-I PHOSPHORYLATION; EXCITOTOXIC BRAIN-INJURY; ALPHA(2)-AGONIST DEXMEDETOMIDINE; ALPHA(2A)-ADRENOCEPTOR SUBTYPE; NEUROTRANSMITTER RELEASE; ALZHEIMERS-DISEASE; MAMMALIAN BRAIN; MAP KINASE;
D O I
10.1016/j.ejphar.2011.08.012
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The present study examined the effect of dexmedetomidine, an alpha(2) adrenoceptor agonist, on endogenous glutamate release in rat cerebral cortex nerve terminals (synaptosomes). We also explored the possible mechanism that triggers dexmedetomidine to act. Dexmedetomidine dose-dependently inhibited the release of glutamate evoked by the K(+) channel blocker 4-aminopyridine. Presynaptic alpha(2A) adrenoceptors were involved in this release inhibition, with the alpha(2A) antagonist (but not by the alpha(2B/C) antagonist) blocking the dexmedetomidine-mediated inhibition. The effect of dexmedetomidine on the evoked glutamate release was prevented by the chelating extracellular Ca(2+) ions, and by the vesicular transporter inhibitor bafilomycin A1. However, the glutamate transporter inhibitor DL-threo-beta-benzyl-oxyaspartate did not have any effect on the action of dexmedetomidine. Dexmedetomidine decreased the degree of depolarization-induced increase in the intrasynaptosomal Ca(2+) levels, but did not affect the synaptosomal membrane potential. The inhibitory effect of dexmedetomidine on evoked glutamate release was abolished by blocking the Ca(v)2.2 (N-type) and Ca(v)2.1 (P/Q-type) channels, but was insensitive to the endoplasmic reticulum ryanodine receptors or mitochondria! Na(+)/Ca(2+) exchange. In addition, the mitogen-activated/extracellular signal-regulated kinase kinase (MEK) inhibitors prevented dexmedetomidine from inhibiting glutamate release. Further, western blotting showed that dexmedetomidine decreased the 4-aminopyridine-induced phosphorylation of mitogen-activated protein kinase/extracellular signal-regulated kinase 1 and 2 and synapsin I, the main presynaptic target of mitogen-activated protein kinase. Thus, we concluded that dexmedetomidine acts at alpha(2A) adrenoceptors present on cerebrocortical nerve terminals inhibit the release of glutamate. We further concluded that this effect is linked to the suppression of voltage-dependent Ca(2+) channels and mitogen-activated protein kinase activity. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:137 / 147
页数:11
相关论文
共 62 条
[1]
IONIC DEPENDENCE OF MEMBRANE-POTENTIAL AND GLUTAMATE RECEPTOR-LINKED RESPONSES IN SYNAPTONEUROSOMES AS MEASURED WITH A CYANINE DYE, DIS-C2-(5) [J].
AKERMAN, KEO ;
SCOTT, IG ;
HEIKKILA, JE ;
HEINONEN, E .
JOURNAL OF NEUROCHEMISTRY, 1987, 48 (02) :552-559
[2]
NONVESICULAR RELEASE OF NEUROTRANSMITTER [J].
ATTWELL, D ;
BARBOUR, B ;
SZATKOWSKI, M .
NEURON, 1993, 11 (03) :401-407
[3]
AN ION CHANNEL LOCUS FOR THE PROTEIN-KINASE-C POTENTIATION OF TRANSMITTER GLUTAMATE RELEASE FROM GUINEA-PIG CEREBROCORTICAL SYNAPTOSOMES [J].
BARRIE, AP ;
NICHOLLS, DG ;
SANCHEZPRIETO, J ;
SIHRA, TS .
JOURNAL OF NEUROCHEMISTRY, 1991, 57 (04) :1398-1404
[4]
Neuronal calcium signaling [J].
Berridge, MJ .
NEURON, 1998, 21 (01) :13-26
[5]
A SYNAPTIC MODEL OF MEMORY - LONG-TERM POTENTIATION IN THE HIPPOCAMPUS [J].
BLISS, TVP ;
COLLINGRIDGE, GL .
NATURE, 1993, 361 (6407) :31-39
[6]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]
BYLUND DB, 1992, MOL PHARMACOL, V42, P1
[8]
α2A- but not α2B/C-adrenoceptors modulate noradrenaline release in rat locus coeruleus:: voltammetric data [J].
Callado, LF ;
Stamford, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 366 (01) :35-39
[9]
Dexmedetomidine: a review of clinical applications [J].
Carollo, Dominic S. ;
Nossaman, Bobby D. ;
Ramadhyani, Usha .
CURRENT OPINION IN ANESTHESIOLOGY, 2008, 21 (04) :457-461
[10]
Hypericin, the active component of St. John's wort, inhibits glutamate release in the rat cerebrocortical synaptosomes via a mitogen-activated protein kinase-dependent pathway [J].
Chang, Yi ;
Wang, Su-Jane .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 634 (1-3) :53-61